Assessment of cardiac dynamics during stress echocardiography by the peak power output-to-left ventricular mass ratio

Future Cardiology

Volumn 7, Issue 3, 2011, Pages 347-356

  Dini, Frank L ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

cardiac power output; exercise; heart failure; left ventricular mass; stress echocardiography

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BLOOD PRESSURE MEASUREMENT; EXERCISE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART RATE; HEART VENTRICLE REMODELING; INOTROPISM; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY;

ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; HEART; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIUM; OXYGEN CONSUMPTION; PROGNOSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 79958093865     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.12     Document Type: Review

References (47)

1. Sengupta PP, Korinek J, Belohlavek M, et al. Left ventricular structure and function. Basic science for cardiac imaging. J. Am. Coll. Cardiol. 48, 1988-2001 (2006). (Pubitemid 44738455)
2. Katz AM: Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N. Engl. J. Med. 322, 100-110 (1990). (Pubitemid 20023868)
3. Risk stratification and survival after myocardial infarction. N. Engl. J. Med. 309, 331-336 (1983).
4. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 87(Suppl. 6), 5-16 (1993).
5. Florea VG, Heneyn MY, Anker SD, et al. Relation of changes over time in ventricular size and function to those in exercise capacity in patients with chronic heart failure. Am. Heart J. 139, 913-917 (2000). (Pubitemid 30305415)
6. Rushmer RF: Cardiovascular Dynamics. Saunders, PA, USA (1961).
7. Opie LH: The Heart. Physiology, from Cell to Circulation. Williams & Wilkins, Lippincott, PA, USA (1998).
8. Klabunde RE: Cardiovascular Physiology Concepts. Williams & Wilkins, Lippincott, PA, USA (2005).
9. Tan LB: Clinical and research implications of new concepts in the assessment of cardiac pumping performance in heart failure. Cardiovasc. Res. 21, 615-622 (1987). (Pubitemid 17128999)
10. Williams SG, Cooke GA, Wright DJ, et al. Peak exercise cardiac power output: a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur. Heart J. 22, 1496-1503 (2001). (Pubitemid 32769177)
11. Schlossan D, Barker D, Pepper C, Williams G, Morley C, Tan LB: CRT improves the exercise capacity and functional reserve of the failing heart through enhancing the cardiac-flow and pressure-generating capacity. Eur. J. Heart Fail. 8, 515-521 (2006). (Pubitemid 44205504)
12. Lang CC, Karlin P, Haythe J, Lim TK, Mancini DM: Peak cardiac power output, measured noninvasively, is a powerful predictor of outcome in chronic heart failure. Circ. Heart Fail. 2, 33-38 (2009).
13. Jakovljevic DG, George RS, Donovan G, et al. Comparison of cardiac power output and exercise performance in patients with left ventricular assist devices, explanted (recovered) patients, and those with moderate to severe heart failure. Am. J. Cardiol. 105, 1780-1785 (2010).
14. Marmor A, Schneeweiss A: Prognostic value of noninvasively obtained left ventricular contractile reserve in patients with severe heart failure. J. Am. Coll. Cardiol. 29, 422-428 (1997). (Pubitemid 27059976)
15. Armstrong GP, Carlier SG, Fukamachi K, Thomas JD, Marwick TH: Estimation of cardiac reserve by peak power: validation and initial application of a simplified index. Heart 82, 357-364 (1999). (Pubitemid 29429612)
16. Otasevic P, Popovic ZB, Vasiljevic JD, et al. Head-to-head comparison of indices of left ventricular contractile reserve assessed by high-dose dobutamine stress echocardiography in idiopathic dilated cardiomyopathy: five-year follow up. Heart 92, 1253-1258 (2006). (Pubitemid 44298873)
17. Marmor A, Raphael T, Marmor M, Blondheim D: Evaluation of contractile reserve by dobutamine echocardiography: noninvasive estimation of the severity of heart failure. Am. Heart J. 132, 1195-1201 (1996). (Pubitemid 26424790)
18. Dini FL, De Tommasi SM: Cardiac mass-to-maximum power output: a novel index to assess left ventricular efficiency during exercise stress echocardiography. Biomed. Pharmacother. 62, 498 (2008).
19. Cohn JN: Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. Circulation 91, 2504-2507 (1995).
20. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 322, 1561-1566 (1990). (Pubitemid 20176696)
21. Sabbah HN, Stein PD, Kono T, et al. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am. J. Physiol. 260, H1379-H1384 (1991).
22. Weber KT, Brilla C: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-aldosterone system. Circulation 83, 1849-1865 (1991).
23. Linzbach AJ: Heart failure from the point of view of quantitative anatomy. Am. J. Cardiol. 5, 370-382 (1960).
24. Boluyt MO, Bing OH, Lakatta EG: The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur. Heart J. 16(Suppl. N), 19-30 (1995). (Pubitemid 26082317)
25. Ross J Jr: Adaptations of the left ventricle to chronic volume overload Circ. Res. 35(Suppl. II), 64-70 (1974).
26. Konstam MA: Systolic and diastolic dysfunction in heart failure? Time for a new paradigm. J. Cardiac Fail. 9, 1-3 (2003). (Pubitemid 36356695)
27. Kajstura J, Zhang X, Liu Y, et al. The cellular basis of pacing induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation 92, 2306-2317 (1995).
28. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV: Factors influencing the one-year mortality of dilated cardiomyopathy. Am. J. Cardiol. 54, 147-152 (1984). (Pubitemid 14085366)
29. Quiñones MA, Greenberg BH, Kopelen HA, et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J. Am. Coll. Cardiol. 35, 1237-1244 (2000). (Pubitemid 30206899)
30. Naqvi TZ, Goel RK, Forrester JS, Siegel RJ: Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 34, 1537-1544 (1999). (Pubitemid 29528669)
31. Ramahi TM, Longo MD, Cadariu AR, et al. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe nonischemic cardiomyopathy. Eur. Heart J. 22, 849-856 (2001). (Pubitemid 32622413)
32. Pinamonti B, Perkan A, Di Lenarda A, Gregori D, Sinagra G: Dobutamine echocardiography in idiopathic dilated cardiomyopathy: clinical and prognostic implications. Eur. J. Heart Fail. 4, 49-61 (2001).
33. Parsai C, Baltabaeva A, Anderson L, Chaparro M, Bijnens B, Sutherland GR: Low-dose dobutamine stress echo to quantify the degree of remodeling after cardiac resynchronization therapy. Eur. Heart J. 30, 950-958 (2009).
34. Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P: Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Eur. Heart J. 21, 927-934 (2000). (Pubitemid 30307422)
35. Pratali L, Picano E, Otasevic P, et al. Prognostic significance of dobutamine echocardiography test in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 88, 1374-1378 (2001). (Pubitemid 34008680)
36. Grosu A, Bombardini T, Senni M, Duino V, Gori M, Picano E: End-systolic pressure/volume relationship during dobutamine stress echo: a prognostically useful non-invasive index of left ventricular contractility. Eur. Heart J. 26, 2404-2412 (2005). (Pubitemid 41552970)
37. Pfeffer MA, Pfeffer JM, Frohlich ED: Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ. Res. 38, 432 (1976).
38. Dini FL, Mele D, Conti U, et al. Peak power output-to left ventricular mass: An index to predict ventricular pumping performance and morbidity in advanced heart failure. J. Am. Soc. Echocardiogr. 23, 1259-1265 (2010).
39. Farzaneh-Far R, Na B, Whooley MA, Schiller NB: Left-ventricular power-to-mass ratio at peak exercise predicts mortality, heart failure, and cardiovascular events in patients with stable coronary artery disease: data from the Heart and Soul Study. Cardiology 114, 226-234 (2009).
40. Schiller NB, Skioldebrand CG, Schiller EJ, et al. Canine left ventricular mass estimation by two-dimensional echocardiography. Circulation 68, 210-216 (1983). (Pubitemid 13058228)
41. Lainchbury JG, Richards AM: Exercise testing in the assessment of chronic congestive heart failure. Heart 88, 538-543 (2002). (Pubitemid 35221974)
42. Mancini DM, Eisen H, Kussmaul W, Muli R, Edmunds LH Jr, Wilson JR: Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83, 778-786 (1991).
43. Kronenberg MW, Konstam MA, Edens TR, et al. Factors influencing exercise performance in patients with left ventricular dysfunction. SOLVD Investigators. Studies of Left Ventricular Dysfunction. J. Cardiac Fail. 4, 159-167 (1998). (Pubitemid 28433918)
44. Griffin BP, Shah PK, Ferguson J, Rubin SA: Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am. J. Cardiol. 67, 848-853 (1991).
45. Roul G, Moulichon M, Bareiss P, et al. Prognostic factors of chronic heart failure in NYHA class III and IV; value of invasive exercise hemodynamic data. Eur. Heart J. 16, 1378-1398 (1995).
46. Metra M, Faggiano P, DAloia A, et al. Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure. J. Am. Coll. Cardiol. 33, 943-950 (1999).
47. Kearney M: Chronic Heart Failure. Oxford University Press, Oxford, UK (2008).